Mallinckrodt obtains FDA approval for StrataGraft to treat thermal burns

Mallinckrodt obtains FDA approval for StrataGraft to treat thermal burns

Source: 
Pharmaceutical Business Review
snippet: 

Mallinckrodt has received the US Food and Drug Administration (FDA) approval for StrataGraft to treat thermal burns with intact dermal elements in adults.